XTalks

NOVEMBER 6, 2020

The Burnaby, BC-based company developed the oral DNA-based vaccine using its proprietary bacTRL Gene Therapy Platform, which uses genetically modified bifidobacteria as carriers of genetic vaccine elements on a DNA plasmid. million from Canada’s National Research Council (NRC) to support the clinical advancement of bacTRL-Spike.

Clinical Trials 75

Clinical Trials Clinical Trials Vaccine Vaccination 75

The Pharma Data

OCTOBER 19, 2020

19, 2020 — Medieval plague outbreaks in England picked up frightening speed in the 17th century, Canadian researchers report. DeGroote Institute for Infectious Disease Research at McMaster University in Hamilton, Ontario. This research suggests that it was not spread by human-to-human transmission. MONDAY, Oct.

Bacterium 52

Bacterium Genetics Research Development 52

Scienmag

OCTOBER 7, 2020

Study will influence the global elimination strategy for yaws Genome sequencing has shed light on the re-emergence of the bacterium that causes yaws, a neglected tropical disease of the skin, bones and joints. Researchers at the […].

Genome 40

Genome Genomics Bacterium Drugs 40

The Pharma Data

JULY 11, 2021

The microbiome has been the focus of research for 20 years – ever since a new technique made it possible to analyse these bacteria quickly and precisely: high-throughput sequencing. The research team published the results of its study in the journal Nature Communications. Fatty acids increase the activity of killer cells.

Bacteria 52

Bacteria Genetics Scientist Regulation 52

The Pharma Data

JUNE 14, 2023

Pseudomonas aeruginosa, a common environmental bacterium, can colonize different body parts, such as the lungs, leading to persistent, chronic infections that can last a lifetime – a common occurrence in people with cystic fibrosis. “Our study took a novel approach to look directly into the bacterium’s behavior in the human host.”

RNA 40

RNA Regulation Scientist Bacteria 40

XTalks

NOVEMBER 10, 2020

The Canadian federal government has pledged $173 million in funding to Medicago for its vaccine research and development, as well as for the construction of its Quebec City manufacturing facility. It has also signed a deal with the company to secure the rights to purchasing 76 million doses of the vaccine.

Vaccine 52

Vaccine Vaccination Trials Immune Response 52

XTalks

DECEMBER 24, 2020

However, for virologists like Lori Frappier, PhD, professor in the department of molecular genetics at the University of Toronto, the outbreak of SARS-CoV-2 was less of a surprise and more of an inevitability. She told Xtalks that, “Experts have always known that this kind of pandemic was a possibility, especially with coronaviruses.

Life Science 111

Life Science Vaccine Vaccination Gene 111